Sudha Sundar is a gynaecological cancer surgeon and a clinical academic. Her research programme focusses on improving cancer diagnostics, cancer surgery and addressing …

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis … AR …

Sudha Sundar’s research interests are in surgical trials in gynaecological cancer, novel therapies in endometrial cancer and minimal invasive radical surgery.

We investigated URS and impact on survival in whole patient cohorts with AOC treated within gynaecological cancer centres that participated in the previously presented SOCQER 2 study.

2024年10月1日 · In a paper published in Lancet Oncology, research funded by the National Institute for Health and Care Research (NIHR) and led by Professor Sudha Sundar from the …

Sudha Sundar Professor of Gynaeological Oncology, Past President of the British Gynaecological Cancer Society ( 2019-2022). National Ovarian Cancer audit lead, UK

IVF in Sudha Sundar Clinic is a major treatment in infertility when other methods of assisted reproductive technology have failed. The process involves hormonally controlling the ovulatory …

Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer. Andrew Phillips, Sudha Sundar, Kavita Singh, James …

How do we deliver safe bowel resection in ovarian cancer cytoreductive surgery? Review activity for European journal of obstetrics, gynecology, and reproductive biology. (1) Review activity …

2019年6月26日 · A Professor in Gynaecological Oncology at the Institute of Cancer and Genomic Sciences, Professor Sundar also serves as the President of the British Gynaecological Cancer …